|
| 36892847 | Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial. | JAMA Oncol | 2023 |
| 37226243 | Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors. | Breast Cancer Res | 2023 |
| 36653664 | Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer. | Ann Surg Oncol | 2023 |
| 36745260 | ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy - Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2-3 Breast Cancer. | Ann Surg Oncol | 2023 |
| 34671883 | Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy? | Ann Surg Oncol | 2022 |
| 35653124 | Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031). | Clin Cancer Res | 2022 |
| 35734391 | Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response. | NAR Cancer | 2022 |
| 35503516 | A review of the current status of lenalidomide maintenance therapy in multiple myeloma in 2022. | Expert Rev Anticancer Ther | 2022 |
| 34855208 | Evaluating educational interventions to increase breast density awareness among Latinas: A randomized trial in a Federally Qualified Health Center. | Cancer | 2022 |
| 35177654 | Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer. | NPJ Breast Cancer | 2022 |
| 35033304 | Breast Density Knowledge and Awareness Among Latinas in a Low-Resource Setting. | J Am Coll Radiol | 2022 |
| 33981951 | Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance). | JNCI Cancer Spectr | 2021 |
| 33766079 | Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study. | Breast Cancer Res | 2021 |
| 34559902 | A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202). | Am J Hematol | 2021 |
| 34078650 | Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY). | Clin Cancer Res | 2021 |
| 34101624 | FOXA1 overexpression suppresses interferon signaling and immune response in cancer. | J Clin Invest | 2021 |
| 34073689 | Future Directions in Maintenance Therapy in Multiple Myeloma. | J Clin Med | 2021 |
| 32538690 | An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer. | Thyroid | 2020 |
| 31809326 | Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma: Results of a Study of Academic and Community Cancer Research United (ACCRU) RU261206I. | Am J Clin Oncol | 2020 |
| 31665365 | Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance). | J Natl Cancer Inst | 2020 |
| 32098767 | Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α. | Clin Cancer Res | 2020 |
| 32589921 | Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling. | Biol Blood Marrow Transplant | 2020 |
| 32699021 | A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial). | Int J Gynecol Cancer | 2020 |
| 32325171 | Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple Myeloma. | Biol Blood Marrow Transplant | 2020 |
| 32430040 | Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer. | Breast Cancer Res | 2020 |
| 30635635 | Commentary on "Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma" by Giovanni Barosi and Robert Peter Gale. | Leukemia | 2019 |
| 31832106 | The emerging role of CDK4/6i in HER2-positive breast cancer. | Ther Adv Med Oncol | 2019 |
| 31852492 | Behavioral and psychological impact of returning breast density results to Latinas: study protocol for a randomized clinical trial. | Trials | 2019 |
| 30193295 | Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial. | JAMA Oncol | 2019 |
| 29884841 | Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models. | Genet Med | 2019 |
| 31211604 | Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM. | J Clin Oncol | 2019 |
| 31231469 | Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall. | Oncotarget | 2019 |
| 31166752 | Comparison of <sup>99m</sup>Tc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy. | AJR Am J Roentgenol | 2019 |
| 30661162 | Should Overall Survival Remain an Endpoint for Multiple Myeloma Trials? | Curr Hematol Malig Rep | 2019 |
| 29289986 | Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer. | Breast Cancer Res Treat | 2018 |
| 30100988 | Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot study. | Oncotarget | 2018 |
| 30013765 | Update on the role of lenalidomide in patients with multiple myeloma. | Ther Adv Hematol | 2018 |
| 30114337 | Patterns of failure following the excision of in-transit lesions in melanoma and the influence of excisional margins. | J Surg Oncol | 2018 |
| 30089255 | Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer. | Cell Rep | 2018 |
| 30257941 | ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis. | Proc Natl Acad Sci U S A | 2018 |
| 30652605 | PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient. | JCO Clin Cancer Inform | 2018 |
| 29666297 | Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG-N0377, Alliance). | Oncologist | 2018 |
| 29708513 | DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine. | J Clin Invest | 2018 |
| 29365023 | Comparison of a Medical-Grade Monitor vs Commercial Off-the-Shelf Display for Mitotic Figure Enumeration and Small Object (Helicobacter pylori) Detection. | Am J Clin Pathol | 2018 |
| 27866278 | Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). | Breast Cancer Res Treat | 2017 |
| 28453704 | Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial. | Ann Oncol | 2017 |
| 28376176 | Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer. | J Natl Cancer Inst | 2017 |
| 29207686 | Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells. | Oncotarget | 2017 |
| 29228549 | ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer. | Oncotarget | 2017 |
| 29029287 | Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer. | J Clin Endocrinol Metab | 2017 |